Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer.

The article presents cancer research on Co-delivery of inhibitor of nuclear factor kappa‐B kinase subunit epsilon (IKBKE) siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer. Topics including IKBKE small interfering RNA (siRNA) inhibits the proliferation, migration, and invasion of TNBC cells; and nanocomplex shows higher cellular uptake and better tumor penetration of the encapsulated cargos.